SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-210803
Filing Date
2023-08-11
Accepted
2023-08-11 16:31:05
Documents
14
Period of Report
2023-08-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d103891d8k.htm   iXBRL 8-K 47375
2 EX-3.1 d103891dex31.htm EX-3.1 14406
3 EX-3.2 d103891dex32.htm EX-3.2 37053
  Complete submission text file 0001193125-23-210803.txt   245200

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kdny-20230811.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20230811_lab.xml EX-101.LAB 18740
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20230811_pre.xml EX-101.PRE 11712
8 EXTRACTED XBRL INSTANCE DOCUMENT d103891d8k_htm.xml XML 3568
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 231164594
SIC: 2834 Pharmaceutical Preparations